PHPYF yields 243.90% · JNJ yields 2.14%● Live data
📍 PHPYF pulled ahead of the other in Year 1
Combined, PHPYF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of PHPYF + JNJ for your $10,000?
Pushpay Holdings Limited, together with its subsidiaries, provides donor management system to the faith sector, non-profit organizations, and education providers in the United States, Canada, Australia, and New Zealand. Its donor management system comprises donor tools, finance tools, and a custom community app. The company provides engagement, payment, and administration solutions, which enable its customers to enhance participation and build stronger relationships with their communities. It also offers Software as a Service church management system, a platform that provides churches to connect and communicate with their community members; record member service history; and track online giving and perform a range of administrative functions, as well as ChurchStaq, an engagement solution that allows users to connect across various ministry touch points, including giving and donor management, church management, and access to Pushpay's App. Pushpay Holdings Limited was incorporated in 2011 and is based in Auckland, New Zealand.
Full PHPYF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.